Evidence map›Paper›PMID 39095510›Full record

ArticleEuropean journal of human genetics : EJHG2024

Correction: EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.

Trudi McDevitt, Miranda Durkie, Norbert Arnold, George J Burghel, Samantha Butler, Kathleen B M Claes, Peter Logan, Rachel Robinson, Katie Sheils, Nicola Wolstenholme and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Trudi McDevitt *Department of Clinical Genetics, Children's Health Ireland at Crumlin, Dublin, Ireland. trudi.mcdevitt@childrenshealthireland.ie.ORCID http://orcid.org/0009-0008-2425-5194
Miranda Durkie *Sheffield Diagnostic Genetics Service, North East and Yorkshire Genomic Laboratory Hub, Sheffield Children's NHS Foundation Trust Western Bank, Sheffield, UK.ORCID http://orcid.org/0000-0001-7071-7048
Norbert ArnoldUKSH Campus Kiel, Gynecology and Obstetrics, Institut of Clinical Chemistry, Institut of Clinical Molecular Biology, Kiel, Germany.
George J BurghelManchester University NHS Foundation Trust, North West Genomic Laboratory Hub, Manchester, UK.ORCID http://orcid.org/0000-0001-9360-8194
Samantha ButlerCentral and South Genomic Laboratory Hub, West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Kathleen B M ClaesGhent University Hospital, Center for Medical Genetics, Gent, Belgium.ORCID http://orcid.org/0000-0003-0841-7372
Peter LoganHSCNI / Belfast Trust Laboratories, Regional Molecular Diagnostics Service, Belfast, Northern Ireland.
Rachel RobinsonLeeds Teaching Hospitals NHS Trust, Genetics Department, Leeds, UK.
Katie SheilsEMQN, Manchester, UK.ORCID http://orcid.org/0000-0002-1649-1495
Nicola WolstenholmeEMQN, Manchester, UK.
Helen HansonSt George's University Hospitals NHS Foundation Trust, Clinical Genetics, London, UK.ORCID http://orcid.org/0000-0002-3303-8713
Clare TurnbullInstitute of Cancer Research, London, UK.
Stacey Hume *University of British Columbia, Pathology and Laboratory Medicine, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-3217-3032

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39095510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.